Sylvia Cheung | Chief Financial Officer |
Joseph Darling | President and Chief Executive Officer |
Mike Petusky | Barrington Research |
Joe Munda | First Analysis |
Lisa Springer | Singular Research |
Mike Petusky | Barrington Research |
Good evening, ladies and gentlemen, and welcome to Anika Therapeutics Fourth Quarter 2018 Earnings Conference Call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded. I will now turn the call over to Sylvia Cheung, Chief Financial Officer.